Zobrazeno 1 - 10
of 173
pro vyhledávání: '"Jin Feng Chen"'
Publikováno v:
Nano Express, Vol 5, Iss 1, p 012001 (2024)
Functionalized carbon quantum dots (CQDs) show great potential for application in the field of food safety. CQDs have attracted widespread attention in this regard due to the wide range of sources of raw materials for their synthesis, and their good
Externí odkaz:
https://doaj.org/article/3a2dde6e91574794a715d6e02601dc5d
Publikováno v:
Yuanzineng kexue jishu, Vol 57, Iss 9, Pp 1750-1760 (2023)
The printed circuit heat exchanger (PCHE) is one of the promising candidates for supercritical CO2 Brayton cycle, its performance is important to the safety and economy of the next generation nuclear technology. In this paper, an experimental study o
Externí odkaz:
https://doaj.org/article/96c2c67281984e70b5c2dc511347acc2
Autor:
Jin Feng Chen, Chan Jiao
Publikováno v:
Ciência Rural, Vol 46, Iss 10, Pp 1743-1749
ABSTRACT: As a gas signaling molecule, endogenous hydrogen sulfide (H2S) plays a crucial role in the plant stress response. However, the role of H2S in the response to organic pollutants specifically has not been studied. Here, the effects of H2S add
Externí odkaz:
https://doaj.org/article/fbbb126281094162a525a640f8135388
Autor:
Jin-Feng Chen, Zhi-Xue Zhao, Yan Li, Ting-Ting Li, Yong Zhu, Xue-Mei Yang, Shi-Xin Zhou, He Wang, Ji-Qun Zhao, Mei Pu, Hui Feng, Jing Fan, Ji-Wei Zhang, Yan-Yan Huang, Wen-Ming Wang
Publikováno v:
Rice, Vol 14, Iss 1, Pp 1-11 (2021)
Abstract Background Rice blast caused by Magnaporthe oryzae is one of the most destructive diseases of rice. An increasing number of microRNAs (miRNAs) have been reported to fine-tune rice immunity against M. oryzae and coordinate with growth and dev
Externí odkaz:
https://doaj.org/article/9e255b120dca495386e45167b9c1c1b0
Publikováno v:
Anti-Cancer Drugs; Jun2024, Vol. 35 Issue 5, p445-449, 5p
Publikováno v:
Blood Pressure Monitoring; Jun2024, Vol. 29 Issue 3, p156-160, 5p
Autor:
Bin Su, Cheng Yao, Qing-Xia Zhao, Wei-Ping Cai, Min Wang, Hong-Zhou Lu, Yuan-Yuan Chen, Li Liu, Hui Wang, Yun He, Yu-Huang Zheng, Ling-Hua Li, Jin-Feng Chen, Jian-Hua Yu, Biao Zhu, Min Zhao, Yong-Tao Sun, Wen-Hui Lun, Wei Xia, Li-Jun Sun, Li-Li Dai, Tai-Yi Jiang, Mei-Xia Wang, Qing-Shan Zheng, Hai-Yan Peng, Yao Wang, Rong-Jian Lu, Jian-Hua Hu, Hui Xing, Yi-Ming Shao, Dong Xie, Tong Zhang, Fu-Jie Zhang, Hao Wu, Xin Chen, Peng Lyu, for the TALENT Study Team
Publikováno v:
Chinese Medical Journal, Vol 133, Iss 24, Pp 2919-2927 (2020)
Abstract. Background. Albuvirtide is a once-weekly injectable human immunodeficiency virus (HIV)-1 fusion inhibitor. We present interim data for a phase 3 trial assessing the safety and efficacy of albuvirtide plus lopinavir-ritonavir in HIV-1-infect
Externí odkaz:
https://doaj.org/article/600b1737073a4fb69251bbb2c287b4fc
Publikováno v:
Blood Pressure Monitoring; Apr2024, Vol. 29 Issue 2, p93-98, 6p
Publikováno v:
Blood Pressure Monitoring; Feb2024, Vol. 29 Issue 1, p41-44, 4p
Autor:
Peng-Le Guo, Hao-Lan He, Xie-Jie Chen, Jin-Feng Chen, Xiao-Ting Chen, Yun Lan, Jian Wang, Pei-Shan Du, Huo-Lin Zhong, Hong Li, Cong Liu, Li-Ya Li, Feng-Yu Hu, Xiao-Ping Tang, Wei-Ping Cai, Ling-Hua Li
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2021)
Dual therapy with lopinavir/ritonavir (LPV/r) plus lamivudine (3TC) has been demonstrated to be non-inferior to the triple drug regimen including LPV/r plus two nucleoside reverse transcriptase inhibitors (NRTIs) in 48-week studies. However, little i
Externí odkaz:
https://doaj.org/article/a1d2329b1e504c37ada601873888b2d7